"So to me, the chemo was a healing experience. I felt good from it." — Marissa

In Part One, Marissa described a decade-long path through progressive Multiple Sclerosis and an aggressive Stage III breast cancer diagnosis that arrived, paradoxically, as a second chance at life. In Part Two, host Dr. Randi Paynter continues the conversation as Marissa begins the chemotherapy regimen designed to treat her cancer — and instead finds that it starts undoing years of neurological damage.

Marissa opens by describing what it's actually like to navigate specialty medication costs and insurance approval, even with pharmacist training and a physician husband in her corner — a candid look at how little clinical fluency protects patients from a system built around cost containment.

As she moves through her ACT chemotherapy regimen, Marissa and Dr. Paynter trace an unexpected biological overlap: two of the chemo drugs prescribed for her cancer appear to have halted her multiple sclerosis in its tracks. This episode's Epi Edit breaks down the emerging science of Immune Reconstitution Therapy (IRT) — the paradigm reshaping how neurologists think about durable MS remission.

Marissa also walks through the surprisingly complex logistics of cold capping to preserve her hair during chemo, and reveals a hereditary ATM gene mutation that shaped both her diagnosis and her family's future cancer screening.

The episode traces her long, nonlinear recovery — from a single Taxotere dose that set her MS back overnight, to relearning to walk, to driving independently for the first time in years.

Correction & Clarification: At approximately 13 minutes into this conversation, Marissa references doxorubicin and cyclophosphamide as having been used clinically to treat aggressive multiple sclerosis. Cyclophosphamide does have documented clinical use in aggressive MS (see research below). Doxorubicin's disease-modifying effects on MS-like disease, however, have so far been demonstrated in animal models only — it is not an established clinical treatment for MS in humans. We're noting this correction for accuracy, and thank Marissa for catching and clarifying it after we spoke.

In this episode, we discuss:
● The Specialty Medication Trap: Why pharmacological training and even a physician spouse can't shield patients from insurance-driven drug pricing and access barriers.
● A Chemo-Induced MS Remission: How two of the chemotherapy drugs used to treat Marissa's breast cancer appear to have halted her multiple sclerosis — and the emerging science of Immune Reconstitution Therapy (IRT).
● Cold Capping, Demystified: The dry ice, timing, and cost logistics behind scalp cooling to prevent hair loss during chemo — and why access to it shouldn't be limited to those who can afford it.
● The ATM Gene: A hereditary risk factor beyond BRCA1/BRCA2, and what a moderate-penetrance mutation means for lifetime breast and pancreatic cancer risk.
● A Long, Nonlinear Recovery: Physical therapy, a serious MS flare triggered by a single chemo dose, and the slow return of mobility and independence — including driving again.
● Becoming Your Own Medical Archivist: What happens when your entire care team turns over, and why documenting your own history is essential.

Go to ChangedByCancer.com for show notes, research citations, and resource links.

Research articles & links referenced:
Immune Reconstitution Therapy Overview: https://pubmed.ncbi.nlm.nih.gov/31649335/
Scalp Cooling Therapy: https://pubmed.ncbi.nlm.nih.gov/41174233/
Cold Caps & Scalp Cooling — General Overview: Breastcancer.org, "Cold Caps and Scalp Cooling Systems." https://www.breastcancer.org/treatment-side-effects/hair-loss/cold-caps-scalp-cooling
The ATM Gene & Breast Cancer: https://pubmed.ncbi.nlm.nih.gov/34068084/
Chemotherapy & MS — Clinical Case Series: https://pubmed.ncbi.nlm.nih.gov/19173204/
Chemotherapy & MS — Exacerbation Case Report: https://pubmed.ncbi.nlm.nih.gov/27027097/
MS Treatment Research: https://pubmed.ncbi.nlm.nih.gov/34033858/

Related listening: Rachel's episode ("The No-Bull Truth") for more on staying organized as your own medical advocate.

Changed By Cancer is hosted by Dr. Randi Paynter, a cancer epidemiologist. This podcast shares personal experiences and systemic issues in healthcare. It is not medical advice. Please consult your own medical team for health-related decisions.